← Back
$AKTS All transactions

Aktis Oncology, Inc.

▲ BUY
9 / 10

Conviction

$ Value

$406K

Shares

22,545

Price

$18

Filed

Jan 12

Why this score? (9/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • Director (+1)
  • 10%+ owner (+1)
  • Cluster: 6 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Kim Helen Susan

Title

CIK

0001422772

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-01-12

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

157,387

Footnotes

Represents shares of the Issuer's Common Stock received upon conversion of shares of the Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock on a 3.8044-for-1 basis without payment of additional consideration. | These shares are held by Vida Ventures II, LLC ("VV II"). VV Manager II, LLC ("VVM II") is the manager of VV II and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and the Reporting Person, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein. | These shares are held by Vida Ventures II-A, LLC ("VV II-A"). VVM II is the manager of VV II-A and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II-A. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and the Reporting Person, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II-A and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein. | The Series A Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 3.8044-for-1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock without payment of additional consideration. | The Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 3.8044-for-1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock without payment of additional consideration.

Filing Info

Accession No.

0001193125-26-010566

Form Type

4

Issuer CIK

0002035832

Kim Helen Susan's History

Date Ticker Type Value
2026-01-12 AKTS C
2026-01-12 AKTS $14.6M
2026-01-12 AKTS C
2026-01-12 AKTS $406K
2026-01-12 AKTS C $0
2026-01-12 AKTS C $0
2026-01-12 AKTS C $0
2026-01-12 AKTS C $0
2025-05-14 PRTA A $0

Other Insiders at AKTS (90d)

Insider Bought Sold Last
Gormley Glenn 2026-04-15